IXIARO

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Singapore, United Kingdom, United States

Active ingredients

The drug IXIARO contains one active pharmaceutical ingredient (API):

1 Japanese encephalitis, live attenuated UNII DZ854I04ZE - JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)

Japanese encephalitis is a disease caused by the mosquito-borne Japanese encephalitis virus (JEV). Japanese Encephalitis Vaccine acts by inducing antibodies that neutralize live JEV. Read about Japanese encephalitis, live attenuated

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IXIARO Japanese Encephalitis Vaccine	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BA02	Encephalitis, Japanese, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BA Encephalitis vaccines
Discover more medicines within J07BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02333279
Country: EE	Ravimiamet	Identifier(s): 1412761
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08501002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 157068
Country: FR	Base de données publique des médicaments	Identifier(s): 62816512
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 153995
Country: HK	Department of Health Drug Office	Identifier(s): 63173
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6921
Country: IT	Agenzia del Farmaco	Identifier(s): 039220013, 039220025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1037141, 1037142
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 139718
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100231080
Country: SG	Health Sciences Authority	Identifier(s): 14108P
Country: US	FDA, National Drug Code	Identifier(s): 42515-002, 62195-051